Correlation Between Neurosense Therapeutics and XORTX Therapeutics
Can any of the company-specific risk be diversified away by investing in both Neurosense Therapeutics and XORTX Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurosense Therapeutics and XORTX Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurosense Therapeutics and XORTX Therapeutics, you can compare the effects of market volatilities on Neurosense Therapeutics and XORTX Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurosense Therapeutics with a short position of XORTX Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurosense Therapeutics and XORTX Therapeutics.
Diversification Opportunities for Neurosense Therapeutics and XORTX Therapeutics
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Neurosense and XORTX is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Neurosense Therapeutics and XORTX Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XORTX Therapeutics and Neurosense Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurosense Therapeutics are associated (or correlated) with XORTX Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XORTX Therapeutics has no effect on the direction of Neurosense Therapeutics i.e., Neurosense Therapeutics and XORTX Therapeutics go up and down completely randomly.
Pair Corralation between Neurosense Therapeutics and XORTX Therapeutics
Given the investment horizon of 90 days Neurosense Therapeutics is expected to generate 0.6 times more return on investment than XORTX Therapeutics. However, Neurosense Therapeutics is 1.65 times less risky than XORTX Therapeutics. It trades about 0.02 of its potential returns per unit of risk. XORTX Therapeutics is currently generating about 0.01 per unit of risk. If you would invest 169.00 in Neurosense Therapeutics on November 2, 2024 and sell it today you would lose (63.00) from holding Neurosense Therapeutics or give up 37.28% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Neurosense Therapeutics vs. XORTX Therapeutics
Performance |
| Timeline |
| Neurosense Therapeutics |
| XORTX Therapeutics |
Neurosense Therapeutics and XORTX Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neurosense Therapeutics and XORTX Therapeutics
The main advantage of trading using opposite Neurosense Therapeutics and XORTX Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurosense Therapeutics position performs unexpectedly, XORTX Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XORTX Therapeutics will offset losses from the drop in XORTX Therapeutics' long position.| Neurosense Therapeutics vs. Quoin Pharmaceuticals Ltd | Neurosense Therapeutics vs. Revelation Biosciences | Neurosense Therapeutics vs. Virax Biolabs Group | Neurosense Therapeutics vs. Nutriband |
| XORTX Therapeutics vs. Context Therapeutics | XORTX Therapeutics vs. Neurosense Therapeutics | XORTX Therapeutics vs. Quoin Pharmaceuticals Ltd | XORTX Therapeutics vs. Ensysce Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |